A detailed history of National Pension Service transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, National Pension Service holds 3,923,066 shares of BMY stock, worth $209 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
3,923,066
Previous 3,852,631 1.83%
Holding current value
$209 Million
Previous $209 Million 22.02%
% of portfolio
0.19%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $2.84 Million - $3.73 Million
70,435 Added 1.83%
3,923,066 $163 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $5.46 Million - $6.19 Million
113,874 Added 3.05%
3,852,631 $209 Million
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $3.84 Million - $4.58 Million
79,191 Added 2.16%
3,738,757 $192 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $5.46 Million - $6.1 Million
94,254 Added 2.64%
3,659,566 $212 Million
Q2 2023

Aug 15, 2023

BUY
$63.71 - $70.74 $11.3 Million - $12.5 Million
177,104 Added 5.23%
3,565,312 $228 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $1.95 Million - $2.21 Million
29,639 Added 0.88%
3,388,208 $235 Million
Q4 2022

Feb 23, 2023

BUY
$68.48 - $81.09 $1.47 Million - $1.74 Million
21,511 Added 0.64%
3,358,569 $242 Million
Q4 2022

Feb 17, 2023

BUY
$68.48 - $81.09 $1.47 Million - $1.74 Million
21,511 Added 0.64%
3,358,569 $242 Million
Q3 2022

Feb 23, 2023

SELL
$0.13 - $76.84 $2,796 - $1.65 Million
-21,511 Reduced 0.64%
3,337,058 $237 Million
Q3 2022

Nov 17, 2022

BUY
$0.13 - $76.84 $5,897 - $3.49 Million
45,369 Added 1.38%
3,337,058 $239 Million
Q2 2022

Aug 17, 2022

BUY
$72.62 - $79.98 $19.1 Million - $21.1 Million
263,250 Added 8.69%
3,291,689 $253 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $5.36 Million - $6.43 Million
87,216 Added 2.97%
3,028,439 $221 Million
Q4 2021

Feb 15, 2022

SELL
$53.63 - $62.52 $1.73 Million - $2.02 Million
-32,339 Reduced 1.09%
2,941,223 $183 Million
Q3 2021

Nov 18, 2021

SELL
$59.17 - $69.31 $58,696 - $68,755
-992 Reduced 0.03%
2,973,562 $176 Million
Q2 2021

Aug 17, 2021

BUY
$61.91 - $67.42 $2.87 Million - $3.12 Million
46,348 Added 1.58%
2,974,554 $199 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $5.13 Million - $5.77 Million
86,450 Added 3.04%
2,928,206 $185 Million
Q4 2020

Feb 19, 2021

BUY
$57.74 - $65.43 $5.48 Million - $6.21 Million
94,903 Added 3.45%
2,841,756 $176 Million
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $2.74 Million - $3.21 Million
-50,052 Reduced 1.79%
2,746,853 $162 Million
Q1 2020

May 27, 2020

BUY
$46.4 - $67.43 $1.24 Million - $1.8 Million
26,680 Added 0.96%
2,796,905 $156 Million
Q4 2019

Feb 21, 2020

BUY
$49.21 - $64.19 $48.8 Million - $63.7 Million
992,372 Added 55.82%
2,770,225 $178 Million
Q3 2019

Nov 15, 2019

BUY
$42.77 - $50.71 $3.59 Million - $4.26 Million
83,976 Added 4.96%
1,777,853 $90.2 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $4.3 Million - $4.75 Million
96,363 Added 6.03%
1,693,877 $76.8 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $2.66 Million - $3.18 Million
59,062 Added 3.84%
1,597,514 $76.2 Million
Q4 2018

Feb 15, 2019

BUY
$48.76 - $63.23 $4.35 Million - $5.64 Million
89,216 Added 6.16%
1,538,452 $78.2 Million
Q3 2018

Nov 15, 2018

BUY
$55.19 - $62.25 $494,943 - $558,258
8,968 Added 0.62%
1,449,236 $90 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $5.38 Million - $6.7 Million
106,428 Added 7.98%
1,440,268 $79.6 Million
Q1 2018

Apr 13, 2018

BUY
$59.92 - $68.98 $388,581 - $447,335
6,485 Added 0.49%
1,333,840 $84.4 Million
Q4 2017

Jan 17, 2018

BUY
$59.94 - $65.35 $1.7 Million - $1.86 Million
28,402 Added 2.19%
1,327,355 $81.3 Million
Q3 2017

Oct 16, 2017

BUY
$55.23 - $63.74 $71.7 Million - $82.8 Million
1,298,953
1,298,953 $81.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.